Literature DB >> 22963878

Antibacterial and antifungal activities of polyketide metabolite from marine Streptomyces sp. AP-123 and its cytotoxic effect.

Mariadhas Valan Arasu1, Veeramuthu Duraipandiyan, Savarimuthu Ignacimuthu.   

Abstract

A Gram positive, filamentous, spore forming antagonistic Streptomyces sp. AP-123 derived from marine region of Andra Pradesh, India, was studied for its medical importance. Among the 210 Streptomyces strains screened at 64.3% exhibited activity against Gram positive bacteria, 48.5% showed activity towards Gram negative bacteria, 38.8% exhibited both Gram positive and negative bacteria and 80.85% strains revealed significant antifungal activity. However, primary screening revealed that Streptomyces sp. AP-123 exhibited significant antimicrobial activity against all the tested bacteria compared to other Streptomyces strains. The presence of l-diaminopimelic acid and glycine in the cell wall hydrolysates and streptomycin resistance indicated the strain belonged to Streptomyces genus. The 16S rDNA gene based phylogenetic affiliation was determined by using bioinformatic tools and it was identified as Streptomyces sp. AP-123 with 99% sequence similarity to Streptomyces flavogriseus. The antimicrobial substances were extracted by hexane and ethyl acetate from spent medium in which Streptomyces sp. AP-123 was cultivated at 30 °C for 5 d. The antimicrobial activity was assessed using broth micro-dilution technique. A compound was obtained by eluting the crude extract using varying concentrations of solvents followed by the chromatographic purification. Based on the IR, (13)C NMR and (1)H NMR spectral data, the compound was identified as polyketide related antibiotic. It exhibited significant antibacterial activity against Gram positive and Gram negative bacteria and also showed a potent cytotoxic activity against cell lines viz. Vero (Green monkey kidney) and HEP2 (laryngeal carcinoma cells) in vitro. The lowest Minimum Inhibitory Concentration (MIC) of the compound against Bacillus subtilis and Staphylococcus aureus were 25 and 37.5 μg mL(-1), respectively. Against Escherichia coli and Pseudomonas aeruginosa it exhibited MIC of 50 and 37.58 μg mL(-1), respectively. However, against Candida albicans and filamentous fungus, Aspergillus niger the MIC values were 12.5 and 25 μg mL(-1), respectively. Cloning and sequence analysis of ketoacyl synthase (KS) gene revealed similarity to the type II polyketide synthase (PKS) gene of Streptomyces species.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963878     DOI: 10.1016/j.chemosphere.2012.08.006

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  28 in total

1.  Antimicrobial potential and taxonomic investigation of piezotolerant Streptomyces sp. NIOT-Ch-40 isolated from deep-sea sediment.

Authors:  Vishnu Priya Padmanaban; Pankaj Verma; Srividhyalakshmi Venkatabaskaran; Thirupathi Keppayan; Dharani Gopal; Ashok Kumar Sekar; Kirubagaran Ramalingam
Journal:  World J Microbiol Biotechnol       Date:  2017-01-02       Impact factor: 3.312

2.  Enhancing Nutritional Quality of Silage by Fermentation with Lactobacillus plantarum.

Authors:  Mariadhas Valan Arasu; Min-Woong Jung; Da Hye Kim; Soundharrajan Ilavenil; Mariamichael Jane; Hyung Su Park; Naif Abdullah Al-Dhabi; Byong Tae Jeon; Ki Choon Choi
Journal:  Indian J Microbiol       Date:  2014-05-21       Impact factor: 2.461

3.  Terpenoid bioactive compound from Streptomyces rochei (M32): taxonomy, fermentation and biological activities.

Authors:  Raasaiyah Pazhanimurugan; Manikkam Radhakrishnan; Thangavel Shanmugasundaram; Venugopal Gopikrishnan; Ramasamy Balagurunathan
Journal:  World J Microbiol Biotechnol       Date:  2016-08-25       Impact factor: 3.312

4.  In-vitro antibacterial, antifungal, antioxidant and functional properties of Bacillus amyloliquefaciens.

Authors:  Shine Kadaikunnan; Thankappan Rejiniemon; Jamal M Khaled; Naiyf S Alharbi; Ramzi Mothana
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-02-22       Impact factor: 3.944

5.  Characterization of saltern based Streptomyces sp. and statistical media optimization for its improved antibacterial activity.

Authors:  Pandiyan Rajeswari; Polpass Arul Jose; Richa Amiya; Solomon Robinson David Jebakumar
Journal:  Front Microbiol       Date:  2015-01-21       Impact factor: 5.640

6.  Draft Genome Sequence of a Biocontrol Rhizobacterium, Chryseobacterium kwangjuense Strain KJ1R5, Isolated from Pepper (Capsicum annuum).

Authors:  Jin-Ju Jeong; Hongjae Park; Byeong Hyeok Park; Mohamed Mannaa; Mee Kyung Sang; In-Geol Choi; Ki Deok Kim
Journal:  Genome Announc       Date:  2016-04-21

7.  In vitro biocontrol activity of halotolerant Streptomyces aureofaciens K20: A potent antagonist against Macrophomina phaseolina (Tassi) Goid.

Authors:  P Shrivastava; R Kumar; M S Yandigeri
Journal:  Saudi J Biol Sci       Date:  2015-12-25       Impact factor: 4.219

8.  Identification and characterization of Streptomyces flavogriseus NJ-4 as a novel producer of actinomycin D and holomycin.

Authors:  Zhaohui Wei; Chao Xu; Juan Wang; Fengxia Lu; Xiaomei Bie; Zhaoxin Lu
Journal:  PeerJ       Date:  2017-07-19       Impact factor: 2.984

9.  Antifeedant, larvicidal and growth inhibitory bioactivities of novel polyketide metabolite isolated from Streptomyces sp. AP-123 against Helicoverpa armigera and Spodoptera litura.

Authors:  Mariadhas Valan Arasu; Naif Abdullah Al-Dhabi; Valsalam Saritha; Veeramuthu Duraipandiyan; Chinnasamy Muthukumar; Sun-Ju Kim
Journal:  BMC Microbiol       Date:  2013-05-13       Impact factor: 3.605

10.  Antibacterial and antibiofilm activities of tryptoquivalines and meroditerpenes isolated from the marine-derived fungi Neosartorya paulistensis, N. laciniosa, N. tsunodae, and the soil fungi N. fischeri and N. siamensis.

Authors:  Nelson M Gomes; Lucinda J Bessa; Suradet Buttachon; Paulo M Costa; Jamrearn Buaruang; Tida Dethoup; Artur M S Silva; Anake Kijjoa
Journal:  Mar Drugs       Date:  2014-01-28       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.